191 related articles for article (PubMed ID: 3114965)
1. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R
World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965
[No Abstract] [Full Text] [Related]
2. Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.
Weber W; Metzger U; Laffer U; Egeli R
Anticancer Res; 1991; 11(1):365-8. PubMed ID: 1902076
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant portal infusion chemotherapy in colorectal cancer.
Metzger U
Recent Results Cancer Res; 1988; 110():95-100. PubMed ID: 3043601
[No Abstract] [Full Text] [Related]
4. [Concepts in the prevention and treatment of liver metastases of colorectal cancer by regional chemotherapy].
Molzahn E; Gruenagel HH; Freund U; Gross D
Chirurg; 1988 Jan; 59(1):34-40. PubMed ID: 2450722
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Wils J; Schlangen J; Naus A
Recent Results Cancer Res; 1986; 100():157-62. PubMed ID: 3755539
[No Abstract] [Full Text] [Related]
6. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
Weder W; Roethlin M; Metzger U; Largiadèr F
Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495
[No Abstract] [Full Text] [Related]
7. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
[TBL] [Abstract][Full Text] [Related]
8. [Intra-portal chemoprevention and therapy of liver metastases].
Laffer U
Z Gastroenterol Verh; 1989 Jul; 24():189-91. PubMed ID: 2474948
[No Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy for colon and rectal cancer.
Fuchs CS; Mayer RJ
Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
[No Abstract] [Full Text] [Related]
10. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J
Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between 2 combinations in the adjuvant chemotherapy of colon and rectum carcinomas].
Delgado GI; Martinez JC; Novo NF; Ferraz Neto JB; Funari A
Rev Paul Med; 1986; 104(4):231. PubMed ID: 3563282
[No Abstract] [Full Text] [Related]
12. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
Beck TM; Hart NE; Woodard DA; Smith CE
Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
[No Abstract] [Full Text] [Related]
13. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Wils J; Schlangen J; Naus A
Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy for advanced colorectal cancer. A pilot study.
Pandya KJ; Chang AY; Qazi R; Rubins J; Asbury R
Am J Clin Oncol; 1986 Feb; 9(1):31-4. PubMed ID: 3082178
[TBL] [Abstract][Full Text] [Related]
16. Rationale and indications for perfusion in liver tumors: current data.
Schwemmle K; Link KH; Rieck B
World J Surg; 1987 Aug; 11(4):534-40. PubMed ID: 3114966
[No Abstract] [Full Text] [Related]
17. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant intraportal chemotherapy for colorectal cancer.
Mulcahy HE; Farthing MJ
Lancet; 1995 May; 345(8958):1184. PubMed ID: 7723575
[No Abstract] [Full Text] [Related]
19. Pilot study on the regional treatment of colorectal liver metastases by intermittent arterial ischaemia with degradable starch microspheres and arterial and portal infusion with mitomycin C plus 5-fluorouracil--a clinical trial led by the Gastrointestinal Tumour Cooperative Group E.O.R.T.C.
Gerard A
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2627-32. PubMed ID: 3137885
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Wernz JC; Kao AK; Muggia FM; Asbury RF
Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
